Havas enters the creator-led, serialized content space with Shape Shifting, a new platform to help brands lead cultural and health conversations.

Holiday whiplash over CTA enforcement, Nvidia stock pops on CES keynote, weight loss drugs drive healthcare costs up.

OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Musk’s Robstown site fits the bill. The factory sits on former farmland in an unincorporated portion of Nueces County in ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...

In recent years, more and more celebrities — like Elon Musk and Whoopi Goldberg — have spoken up about using GLP-1 ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

CEO Will Johnson wrote, finding Harris data that (60%) of Gen Z spend at least four hours a day scrolling, with an equal number citing the negative impacts of social media on society (60% v. positive: ...

Andrew here. Happy New Year and happy Saturday. This morning, we’re taking a look at what may — or may not — happen in 2025.